David L Rimm MD, PhD

Professor of Pathology; Director of Pathology Tissue Services; Director of Translational Pathology

Departments & Organizations

Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development: Cytoskeleton and Cell Morphogenesis | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Cancer Center, Yale: Signal Transduction

Skin Diseases Research Center, Yale

Pathology: Cytology | Surgical Pathology | Pathology Research | Rimm Lab

Research Interests

Quantitative Pathology; Cancer Tissue Biomarkers; Melanoma; Breast Cancer; Cell-cell adhesion in cancer; Translation of molecular techniques to diagnostic cytopathology; General Cytopathology; Immunohistochemistry; thyroid pathology more...

Education

• M.D., Johns Hopkins University, 1989
• Ph.D., Johns Hopkins University, 1989

Selected Publications

• Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA, Min C, Jaskelioff M, Xiao Y, Wu CJ, Cameron LA, Perry SR, Zeid R, Feinberg T, Kim M, Vande Woude G, Granter SR, Bosenberg M, Chu GC, Depinho RA, Rimm DL, Chin L. (2011) Proinvasion metastasis drivers in early-stage melanoma are oncogenes, Cancer Cell 20:92-103
• Welsh AW, Moeder CB, Kumar S, Gershkovich P, Alarid ET, Harigopal M, Haffty BG, Rimm DL: (2011) Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells, J Clin Oncol 29, 2978-2984
• Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA: (2011) Cancer and leukemia group B pathology committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues, J Clin Oncol 2011, 29:2282-2290

more...